Skip to main content
Premium Trial:

Request an Annual Quote

Concerns and Retaliation

A chiropractor in Chicago alleges he was retaliated against after raising concerns about crowding at a COVID-19 testing site next to his office, NBC5 Chicago reports.

It adds that William Rasmussen, the chiropractor, contacted the news station in January after trying to work with the Center for COVID Control, the company that ran the site, and his landlord to alleviate the crowding issue, but that Rasmussen says there was no change and that he further received no response from federal, state, or local officials. Now, Rasmussen tells NBC5 Chicago that after it aired a segment mentioning his concerns, he received a notice to vacate his office, despite not missing any rent payments, which he took as a sign of retaliation.

NBC5 Chicago adds that the Center for COVID Control is under investigation by federal regulators and said in January it would shut down its operations. The site next to Rasmussen's office, it notes, has reopened as a testing site, but under a new company, Nationwide COVID Testing, whose owner says it has no relationship with the Center for COVID Control and that it has strict safety rules and plans to implement appointments if there is a surge in infections.

Filed under

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.